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Abstract
Background: HIV care providers may be optimally positioned to promote smoking behaviour change in their
patients, among whom smoking is both highly prevalent and uniquely harmful. Yet research on this front is scant,
particularly in the developing country context. Hence, this study describes smoking behaviour among people living
with HIV/AIDS (PLWHA) in the Kathmandu Valley of Nepal, and assesses the association between experience of
physician-delivered smoking status assessment and readiness to quit among HIV-positive smokers.
Methods: We conducted a cross-sectional survey of PLWHA residing in the Kathmandu Valley, Nepal. Data from
321 adult PLWHA were analyzed using multiple logistic regression for correlates of current smoking and, among
current smokers, of motivational readiness to quit based on the transtheoretical model (TTM) of behaviour change.
Results: Overall, 47% of participants were current smokers, with significantly higher rates among men (72%), ever-
injecting drug users (IDUs), recent (30-day) alcohol consumers, those without any formal education, and those with
higher HIV symptom burdens. Of 151 current smokers, 34% were thinking seriously of quitting within the next 6
months (contemplation or preparation stage of behaviour change). Adjusting for potential confounders, experience
of physician-delivered smoking status assessment during any visit to a hospital or clinic in the past 12 months was
associated with greater readiness to quit smoking (AOR = 3.34; 95% CI = 1.05,10.61).
Conclusions: Roughly one-third of HIV-positive smokers residing in the Kathmandu Valley, Nepal, are at the
contemplation or preparation stage of smoking behaviour change, with rates significantly higher among those
whose physicians have asked about their smoking status during any clinical interaction over the past year.
Systematic screening for smoking by physicians during routine HIV care may help to reduce the heavy burden of
smoking and smoking-related morbidity and mortality within HIV-positive populations in Nepal and similar settings.
Background
As expanding global application of antiretroviral therapy
(ART) heralds a paradigm shift in HIV-related morbidity
and mortality [1-5], the time is ripe to address tobacco
smoking as a bottleneck to gains in life expectancy
among people living with HIV/AIDS (PLWHA) [6,7].
Recent studies from HIV-positive cohorts in developed
country settings indicate that rates of current smoking
(41-66%) [7-10] are two to three times higher than corre-
sponding general population rates, and similarly elevated
smoking rates have been observed among PLWHA in
developing African countries [11-14]. In addition to
accelerating the development of well-known tobacco-
associated morbidities [15], smoking weakens the body’s
immune and virological response [16], rendering HIV-
positive smokers more vulnerable to disease and oppor-
tunistic infection and less responsive to ART [17,18].
PLWHA who smoke report lower quality of life and face
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any medium, provided the original work is properly cited.significantly elevated risks of non-AIDS cancers, cardio-
vascular disease, bacterial pneumonia, and all-cause mor-
tality relative to non-smoking PLWHA [8,10,19-21].
Yet even for individuals with protracted tobacco use his-
tories, cessation brings almost immediate health benefits
and can, over time, reduce the risk of premature death to
a level approaching that of a lifetime non-smoker [22,23].
From an HIV-specific perspective, evidence confirms that
quitting smoking can dramatically relieve symptom bur-
den [24] and improve health outcomes, including reduced
risk of bacterial pneumonia [25] and cardiovascular disease
[26]. Moreover, facilitation of smoking cessation alongside
HIV treatment may help prevent medication failures and
substance use relapse [27,28].
A key component and predictor of successful outcomes
in the process of smoking cessation is motivational readi-
ness to change [29,30], described in the transtheoretical
model (TTM) of health behaviour change [31,32]. In the
case of smoking, one study suggests that advancement
from precontemplation (not thinking of quitting within
the next 6 months) to contemplation (thinking of quitting
in the next 1-6 months) increases the likelihood of future
(2-year) cessation by 40%, and that advancement to pre-
paration (thinking of quitting within the next 30 days,
with at least one 24-hour quit attempt in the past year)
increases that likelihood by 80% [30]. Among HIV-positive
smokers, several cross-sectional studies carried out in the
United States report that 58-64% of those treated in outpa-
tient clinics are thinking seriously of quitting within the
next 6 months [9,33-35], indicating a certain readiness and
likelihood to proceed through the remaining stages of
change. Understanding what characteristics or inputs
might impact readiness to quit among HIV-positive smo-
kers is key to devising effective strategies to promote
cessation.
One promising vehicle for reaching HIV-positive smo-
kers may lie in the frequent contact between HIV-positive
smokers and their physicians facilitated by the need for
regular immunologic monitoring and, for many, ART sup-
port. Given this heightened level of interaction and trust
[36], HIV medical systems and personnel would seem ide-
ally placed to effect behaviour change in this important
population of smokers. Indeed, a previous study carried
out among state employees in the United States identified
patients’ trust in their physician and physicians’ knowledge
of patients as leading correlates of adherence to physician’s
advice [37].
Within the general population, even simple interven-
tions delivered by physicians in the form of brief encour-
agement or advice to quit smoking can have a significant
impact on short-term movement through the stages of
change [38] and on future quitting rates [39]. However,
the effect of such basic interventions remains unclear in
the context of HIV care systems, where the space for
positive impact may be even greater. If shown effective,
the implementation of such basic awareness-raising mea-
sures could represent an important first step toward tack-
ling the troubling intersection of HIV and tobacco
epidemics, particularly in the hard-hit and resource-lim-
ited countries of the developing world.
Despite the exceptional health risks associated with
tobacco smoking and the clear benefits of quitting for
HIV-positive smokers, attention to smoking behaviour
and motivational readiness to quit has been inadequate in
this important smoking subgroup. Moreover, although
over 90% of the world’s HIV-positive population resides in
the developing world [40], data on tobacco use among
PLWHA outside of Europe and North America have been
limited to several descriptive reports from Africa [11-14].
We therefore explored factors associated with current
smoking status and readiness to quit among PLWHA
residing in the Kathmandu Valley of Nepal, among the
least developed countries in South Asia. In particular, this
study examined the association between experience of
physician-delivered smoking status assessment and moti-
vational readiness to quit in HIV-positive smokers.
Methods
Study design and setting
This cross-sectional study surveyed a community-based
sample of 321 HIV-positive residents of the Kathmandu
Valley, Nepal. Since the country’s first case of HIV was
reported in 1988, Nepal has been facing a burgeoning
concentrated epidemic, with prevalence especially high
among injecting drug users (IDUs) [41]. In the capital city
of Kathmandu, HIV prevalence among IDUs was 34.8% in
2007 [42]. The Kathmandu Valley comprises three dis-
tricts (Kathmandu, Lalitpur, and Bhaktapur) with an esti-
mated population of 2.2 million [43]. Of Nepal’s estimated
70,000 adult (15-49 years) PLWHA [41], 15.7% were resid-
ing in the Kathmandu Valley at the end of 2006 [44].
Data collection
We recruited 322 participants through purposive, conveni-
ence sampling techniques. Potential participants were
referred through staff members of five local non-govern-
mental organizations (NGOs) working within HIV-positive
communities in the Kathmandu Valley. Individuals
recruited for participation fulfilled the following inclusion
criteria: (1) 16 to 60 years of age, (2) self-reported diagno-
sis of HIV-positive status, and (3) willing provision of writ-
ten informed consent for voluntary participation.
Data collection was undertaken during February and
March 2010 in the wider context of the baseline phase of
a longitudinal healthy living intervention overseen by the
second author (KCP). The survey was based on a struc-
tured, pre-tested Nepali language questionnaire. Trained
interviewers administered the questionnaire face-to-face
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mately 45-60 minutes. All participants were informed
about the study procedures using a prepared information
sheet, and signed informed consent forms prior to being
interviewed. To enhance confidentiality, interviewers
reassured participants that numerical codes would be
used in place of names in all records. The study protocol
was reviewed and ethical approval granted by the Institu-
tional Review Board of the Graduate School of Medicine
at the University of Tokyo and by the Nepal Health
Research Council.
Measures
Sociodemographic, clinical, and psychosocial characteristics
Standard single questionnaire items assessed basic socio-
demographic and HIV-specific clinical variables. We
used the HIV Symptom Index (HSI) [45], which assesses
the presence and degree of 20 symptoms commonly
experienced by PLWHA, to measure HIV symptom bur-
den (Cronbach’sa l p h a=0 . 8 9 ) .P a r t i c i p a n t sr e p o r t e d
whether each symptom was present, and if so, whether it
was bothersome, by using a five-point Likert scale (0-4)
ranging from “I do not have this symptom” (0) to “Ih a v e
i ta n di tb o t h e r sm eal o t ” (4). We dichotomized each
item into absent/not bothersome (0-2) vs. present and
bothersome (3-4), and summed these scores to obtain a
bothersome symptom count [45].
A modified 7-item version of the AIDS-related Stigma
Scale [46] was used to assess internalized AIDS stigma
(Cronbach’s alpha = 0.74). Responses were given dichoto-
mously (0 = disagree, 1 = agree); scale scores represent
the sum total of endorsed items, with higher scores indi-
cating more negative attitudes or perceived discrimina-
tion. Additionally, the 21-item Beck Depression
Inventory (BDI), Nepali version [47,48], was used to
assess depression in participants (Cronbach’sa l p h a=
0.90).
Smoking-related variables
Current smoking status was assessed by single items ask-
ing participants about smoking frequency at the time of
the survey and about amount smoked both daily and
cumulatively. Based on definitions set forth by the CDC
[49], we classified participants as current smokers if they
reported smoking “every day” or “some days” at the time
of survey. Participants who had smoked at least 100
cigarettes in their lifetime but had quit smoking at the
time of the interview were considered former smokers,
while those reporting never smoking or smoking fewer
than 100 cigarettes in their lifetime were considered
never smokers.
Frequency of smoking as a measure of smoking inten-
sity was assessed by asking current smokers how many
cigarettes they smoked in a typical day. Current smokers
were then categorized as light smokers (≤ 10 cigarettes/
day) or moderate-to-heavy smokers (> 10 cigarettes/day)
[50]. Current smokers were also asked whether they
smoked fewer, more, or about the same number of cigar-
ettes since finding out they were HIV-positive [51]. We
identified previous quit attempts by asking current smo-
kers whether they had stopped smoking for at least one
d a yd u r i n gt h ep a s t1 2m o n t h sb e c a u s et h e yw e r et r y i n g
to quit smoking. Additional items addressed to current
smokers covered age of smoking initiation and cohabita-
tion with other smokers.
Health care provider-delivered smoking status assessment
Experience of smoking status assessment by a health care
provider was measured by first asking all participants their
frequency of visits to a hospital or clinic for any reason
over the 12 months preceding the time of survey. Those
reporting at least one visit to a hospital or clinic during
that time (n = 302) then responded to three items inquir-
ing whether a physician, paramedic, or nurse had ever
asked about their smoking status during any such visit.
Readiness to quit smoking
Current smokers’ readiness to quit smoking was assessed
based on the following question: “Are you seriously think-
ing of quitting smoking?” According to the conventions of
the TTM [29], participants reporting no intention to quit
within the next 6 months or no intention to quit at all
were placed in the pre-contemplation stage, while those
reporting an intention to quit in the next 1-6 months were
classified as falling within the contemplation stage. Those
expressing an intention to quit within the next 30 days
and also reporting a previous quit attempt in the past 12
months were categorized in the preparation stage of
change.
Statistical analysis
Of 322 eligible participants, data from one male partici-
pant was incomplete and thus excluded from analysis.
The remaining 321 HIV-positive individuals (184 males,
137 females) constituted our study sample.
Multiple logistic regression analysis was used to explore
factors associated with smoking status and to examine the
association between experience of physician-delivered
smoking status assessment and readiness to quit smoking,
comparing current smokers in lower (pre-contemplators)
and higher (contemplators and preparators) stages of
change in terms of potential covariates. Independent vari-
ables were entered into each regression using a direct
(simultaneous) entry method. Major sociodemographic
characteristics and other mediators having previously
established or theoretically feasible associations with the
dependent variables were included as covariates or poten-
tial confounders in the analyses. Multicollinearity was also
assessed for each model, and the variance inflation factor
(VIF) of all variables was less than 3.0. All statistical tests
were 2-sided, considered significant at the p < 0.05 level,
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(SPSS Inc., Chicago, IL).
Results
Background characteristics
The surveyed group was 57% male and had a median age
of 33 (interquartile range [IQR] = 30, 39) years; 81% of
participants had at least some formal education (Table 1).
Median period since testing HIV-positive was 53 (IQR =
25, 84) months and 73% of participants were on ART at
the time of survey. Median bothersome HIV symptom
count was 3 (IQR = 1, 7), and around a quarter (26%) of
participants registered moderate-to-severe depression.
Overall, 41% of participants had a lifetime history of inject-
ing drug use.
Smoking prevalence and characteristics
Of the 321 participants, 47% were current smokers at the
time of survey - 72% of male and 15% of female partici-
pants. Median age of smoking initiation among the 152
current smokers was 14 years (IQR = 12, 17 years), and
roughly half (51%) were moderate-to-heavy smokers
(Table 2). Nearly two-thirds (62%) of all current smokers
reported some change in their level of smoking since test-
ing HIV-positive, with 45% reporting a reduction and 17%
reporting an increase. A total of 23 participants (19 men,
4 women) had quit smoking subsequent to testing HIV-
positive.
Regarding readiness to quit, 51 current smokers (34%)
had reached or surpassed the contemplation stage of
change, with some thought of quitting within the next six
months. Roughly half (52%) of current smokers had made
at least one quit attempt within the past 12 months; the
most commonly cited reason for relapse was “Addiction/
Habit” (45%), followed by “Boredom” (32%).
Among the 137 current smokers reporting at least one
visit to a hospital or clinic within the past 12 months, 73%
reported experience of physician-delivered smoking status
assessment during any such visit. Further, 26% reported
experience of paramedic- or nurse-delivered smoking sta-
tus assessment within the same parameters.
Factors associated with current smoking
Men were over nine times more likely than women to be
current smokers (AOR = 9.20; 95% CI = 3.80, 22.26)
(Table 3). Additionally, current smoking was nearly six
times as prevalent among participants with a lifetime his-
tory of injecting drug use (AOR = 5.72; 95% CI = 2.74,
11.92), over three times as prevalent among those report-
ing any alcohol consumption in the past 30 days (AOR =
3.19; 95% CI = 1.10, 9.30), and twice as prevalent among
those with higher HIV symptom burdens (AOR = 2.06;
95% CI = 1.04, 4.10). Conversely, participants having any
Table 1 Background characteristics of participants
(N = 321)
Characteristic n
a (%)
Sociodemographics
Gender
Male 137 (57.3)
Female 184 (42.7)
Age (years)
20-29 78 (34.2)
30-39 165 (47.0)
40-60 76 (18.8)
Current marital status
Unmarried 101 (31.5)
Married 220 (68.5)
Education level
b
No formal education 58 (18.6)
Primary (1-5 yrs.) 68 (21.9)
Lower secondary (6-10 yrs.) 156 (50.2)
Higher secondary and above (11+ yrs.) 29 (9.3)
Monthly income (NRs)
c (Median = 4000)
0 89 (28.3)
200-4000 80 (25.4)
4001-300000 146 (46.3)
Any children
No 102 (31.8)
Yes 219 (68.2)
Sexual orientation
Heterosexual 319 (99.4)
Homo- or bi-sexual 2 (0.6)
Clinical and psychosocial characteristics
Months since first testing HIV+ (Median = 53)
1-53 158 (50.0)
54+ 158 (50.0)
Months on ART (Median = 24)
Not currently on ART 87 (27.2)
1-24 129 (40.3)
25+ 104 (32.5)
Experience of TB diagnosis since testing HIV+
No 236 (73.5)
Yes 85 (26.5)
Bothersome HIV symptom count (Median = 3)
0-3 173 (53.9)
4-20 148 (46.1)
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than those without any formal education to be current
smokers (AOR = 0.35; 95% CI = 0.14, 0.84).
Factors associated with readiness to quit smoking
Experience of physician-delivered smoking status assess-
ment during any visit to a hospital or clinic in the last
12 months was significantly associated with higher
readiness to quit among the surveyed HIV-positive smo-
kers (AOR = 3.34; 95% CI = 1.05, 10.61) (Table 4).
Additionally, current smokers reporting at least one
prior quit attempt in the past 12 months were signifi-
cantly more likely than those reporting no such attempt
to be contemplating quitting within the next 6 months
(AOR = 3.77; 95% CI = 1.48, 9.58), as were smokers
having at least one other regular smoker in the house-
hold (AOR = 2.91; 95% CI = 1.16, 7.29). Conversely,
having any formal education was significantly associated
with being in the precontemplative stage of behaviour
change, showing an inverse relationship with readiness
to quit (AOR = 0.12; 95% CI = 0.02, 0.71).
Discussion
This study revealed that HIV-positive smokers reporting
experience of physician-delivered smoking status assess-
ment during any visit to a hospital or clinic in the past
12 months were over three times more likely to be in
the contemplation or preparation stage of readiness to
quit smoking. Outside of gender, lifetime history of
injecting drug use showed the most robust association
with current smoking status, followed by 30-day alcohol
consumption, lack of formal education, and HIV symp-
tom burden. Thus, optimal targeting of high-risk groups
for smoking cessation efforts within the HIV-positive
community would focus especially on males and reco-
vering or active IDUs, incorporating the physician as a
viable conduit for smoking cessation interventions.
Table 1 Background characteristics of participants
(N = 321) (Continued)
Smoking status
Never smoker 129 (40.2)
Former smoker 40 (12.5)
Current smoker 152 (47.4)
Injection drug use history
d
Never user 191 (60.1)
Former user 100 (31.4)
Current user 27 (8.5)
Alcohol use, last 30 days
No 281 (87.5)
Yes 40 (12.5)
Marijuana use, last 6 months
No 290 (90.3)
Yes 31 (9.7)
Internalized AIDS stigma score (Median = 4)
0-4 187 (58.3)
5-7 134 (41.7)
Beck Depression Inventory score
e
< 20 239 (74.5)
20+ 82 (25.5)
NRs, Nepalese Rupees. ART, antiretroviral therapy.
a Total sample size varies due to missing data.
b Based on the structure of the Nepalese education system.
c 4000 NRs = US $55 approximately, as of February 2010.
d Former users: participants reporting a lifetime history of injecting drug use
but no use in the last 6 months classified. Current users: participants reporting
injecting drug use in the last 6 months. Never users: participants reporting no
lifetime history of injecting drug use. Three participants who indicated a
lifetime history of injecting drug use did not respond to the question
regarding 6-month use and hence could not be distinguished as former or
current users.
e A score of 20 or more on the Beck Depression Inventory defined the
presence of moderate-to-severe depressive symptoms, based on clinical
validation of the scale in Nepal (sensitivity = 0.73, specificity = 0.91) [48].
Table 2 Tobacco use characteristics of current smokers
(N = 152)
Characteristic n
a (%)
Age of smoking initiation (years) (Median = 14)
7-14 78 (51.7)
15+ 73 (48.3)
Average daily smoking intensity, last 30 days
Light smoker (≤ 10 cigarettes/day) 75 (49.3)
Moderate-to-heavy smoker (> 10 cigarettes/day) 77 (50.7)
Presence of other smoker in household
No 70 (46.1)
Yes 82 (53.9)
Change in smoking level since testing HIV+
Cut down 68 (44.7)
About the same 58 (38.2)
Increased 26 (17.1)
Readiness to quit smoking (Stage of change)
Pre-contemplation 100 (66.2)
Contemplation 26 (17.2)
Preparation 25 (16.6)
Prior quit attempt, last 12 months
No 74 (48.7)
Yes 78 (51.3)
a Total numbers of respondents vary due to missing data.
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among PLWHA in our study, particularly among male
participants. Though our data reveal a current smoking
prevalence among HIV-positive women roughly compar-
able to the national rate for women in the region
(16.0%), the prevalence of smoking among HIV-positive
men was over twice the corresponding national rate
(34.8%) [52]. Identified predictors of current smoking
status were generally consistent with results of previous
studies conducted within HIV-positive populations in
Western, developed settings [10,33] and in Africa [11].
In terms of motivational readiness to quit, the propor-
tion of participants still in the precontemplative stage of
behaviour change was high relative to previous findings
on HIV-positive smokers in developed countries
[9,33,34]. Velicer et al. [53] reported typical proportions
for readiness to quit as 40% in precontemplation, 40%
in contemplation, and 20% in preparation among smo-
kers in the general population. In our sample, in con-
trast, roughly two-thirds of smokers were
precontemplative about quitting. This finding under-
scores the prime importance of exploring effective ways
to build motivation for cessation in this important
population of smokers.
Our study is the first to report on formal education as
a potential barrier to quitting readiness among HIV-
Table 3 Multiple logistic regression analysis of factors
associated with current smoking
a among participants
(N = 301
b)
Variable AOR (95% CI)
Gender
Male 9.20 (3.80, 22.26)**
Female (Ref) 1.00
Age (years)
34+ 0.72 (0.36, 1.43)
20-33 (Ref) 1.00
Marital status
Married 0.92 (0.43, 1.96)
Unmarried (Ref) 1.00
Any formal education
Yes 0.35 (0.14, 0.84)*
No (Ref) 1.00
Monthly income (NRs)
c
4001+ 0.74 (0.39, 1.40)
0-4000 (Ref) 1.00
Any children
Yes 1.03 (0.49, 2.16)
No (Ref) 1.00
Months since first testing HIV+
54+ 1.51 (0.79, 2.89)
1-53 (Ref) 1.00
Currently receiving ART
Yes 0.77 (0.36, 1.65)
No (Ref) 1.00
Bothersome HIV symptom count
4-20 2.06 (1.04, 4.10)*
0-3 (Ref) 1.00
Experience of TB diagnosis since testing HIV+
Yes 0.73 (0.40, 1.48)
No (Ref) 1.00
Internalized AIDS stigma score
5-7 0.84 (0.44, 1.62)
0-4 (Ref) 1.00
Beck Depression Inventory score
d
20+ 0.49 (0.22, 1.11)
< 20 (Ref) 1.00
Lifetime injecting drug use
Table 3 Multiple logistic regression analysis of factors
associated with current smoking
a among participants
(N = 301
b) (Continued)
Yes 5.72 (2.74, 11.92)**
No (Ref) 1.00
Alcohol consumption, last 30 days
Yes 3.19 (1.10, 9.30)*
No (Ref) 1.00
Marijuana use, last 6 months
Yes 2.59 (0.73, 9.15)
No (Ref) 1.00
Presence of smoker among other household members
Yes 1.09 (0.58, 2.02)
No (Ref) 1.00
AOR, adjusted odds ratio. CI, confidence interval. ART, antiretroviral therapy.
a The reference group was current non-smokers.
b After accounting for the collective set of missing values associated with the
variables included in the multivariable model, data from 301 participants were
analyzed.
c 4000 NRs = US $55 approximately, as of February 2010.
d A score of 20 or more on the Beck Depression Inventory defined the
presence of moderate-to-severe depressive symptoms, based on clinical
validation of the scale in Nepal (sensitivity = 0.73, specificity = 0.91) [48].
*p < 0.05; **p < 0.01.
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lation between education and the quit ratio (proportion
of ever smokers who had quit smoking) demonstrated
by Wetter et al. [54], it may be that those formally edu-
cated individuals still smoking at the time of our survey
were less likely to be thinking seriously of quitting
Table 4 Multiple logistic regression analysis of factors
associated with readiness to quit (contemplation or
preparation stage of change)
a among current smokers
visiting a hospital or clinic in the past 12 months
(N = 131
b)
Variable AOR (95% CI)
Gender
Male 5.79 (0.86-39.10)
Female (Ref) 1.00
Age (years)
34+ 1.10 (0.40-3.03)
20-33 (Ref) 1.00
Marital status
Married 1.30 (0.39-4.30)
Unmarried (Ref) 1.00
Any formal education
Yes 0.12 (0.02-0.71)*
No (Ref) 1.00
Monthly income (NRs)
c
4001+ 0.97 (0.39-2.41)
0-4000 (Ref) 1.00
Any children
Yes 1.30 (0.42-4.05)
No (Ref) 1.00
Months since first testing HIV+
54+ 0.97 (0.37-2.49)
1-53 (Ref) 1.00
Currently receiving ART
Yes 0.71 (0.26-1.93)
No (Ref) 1.00
Bothersome HIV symptom count
4-20 0.50 (0.19-1.32)
0-3 (Ref) 1.00
Experience of TB diagnosis since testing HIV+
Yes 0.80 (0.25-2.51)
No (Ref) 1.00
Number of hospital visits, last 12 months
3+ 0.87 (0.32-2.39)
1-2 (Ref) 1.00
Beck Depression Inventory score
d
20+ 1.20 (0.41-3.57)
< 20 (Ref) 1.00
Table 4 Multiple logistic regression analysis of factors
associated with readiness to quit (contemplation or pre-
paration stage of change)
a among current smokers visit-
ing a hospital or clinic in the past 12 months (N = 131
b)
(Continued)
Lifetime injecting drug use
Yes 0.50 (0.16-1.60)
No (Ref) 1.00
Presence of smoker among other household
members
Yes 2.91 (1.16-7.29)*
No (Ref) 1.00
Age of smoking initiation (years)
15+ 1.67 (0.67-4.15)
7-14 (Ref) 1.00
Average daily smoking intensity, last 30 days
Moderate-to-heavy smoker (> 10 cigarettes/
day)
0.42 (0.16-1.13)
Light smoker (≤ 10 cigarettes/day) (Ref) 1.00
Prior quit attempt, last 12 months
Yes 3.77 (1.48-9.58)
**
No (Ref) 1.00
Experience of smoking status assessment
by a physician, last 12 months
Yes 3.34 (1.05-10.61)
*
No (Ref) 1.00
Experience of smoking status assessment
by paramedic or nurse, last 12 months
Yes 1.01 (0.36-2.85)
No (Ref) 1.00
AOR, adjusted odds ratio. CI, confidence interval. ART, antiretroviral therapy.
a The reference group was current smokers in the precontemplation stage of
change.
b After accounting for the collective set of missing values associated with the
variables included in the multivariable model, data from 131 participants were
analyzed.
c 4000 NRs = US $55 approximately, as of February 2010.
d A score of 20 or more on the Beck Depression Inventory defined the
presence of moderate-to-severe depressive symptoms, according to clinical
validation of the scale in Nepal (sensitivity = 0.73, specificity = 0.91) [48].
*p < 0.05; **p < 0.01.
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continue smoking, fully cognizant of the attendant risks.
Further research would be warranted to elucidate the
observed association between education level and readi-
ness to quit smoking among PLWHA and in the devel-
oping country context.
Similarly, though data from developed countries suggest
that smokers attempting to quit may be less successful
and more susceptible to relapse with the presence of
another smoker in the household [55,56], our data indicate
that cohabitation with at least one other smoker may con-
tribute to greater quitting readiness in some populations.
Indeed, social support networks comprise an important
aspect of successful smoking cessation [57]. Although this
study did not specifically address the readiness to quit of
smoking family members, we can reasonably assume that
some discussion of quitting is likely to take place where
more than one smoker inhabits a household. Future
research might fruitfully explore cessation interventions
designed to exploit existing support systems through soli-
citing the involvement of other household smokers.
We further found that history of at least one smoking
cessation attempt was associated with greater quitting
readiness. This finding is consistent with the TTM, by
which the probability of successful change increases with
the number of change attempts [32], and is also supported
by results from previous studies of HIV-positive smokers
[9]. For the promotion of active progression through the
stages of change toward cessation, this result recommends
the importance of encouraging quit attempts even among
those smokers demonstrating lower levels of motivational
readiness.
Finally, our research opens up a new and previously
unexplored space for the role and effectiveness of basic
smoking status screening administered by physicians treat-
ing PLWHA. Because the HIV practice pattern typically
consists of regular contact over an extended period of
time, physicians treating PLWHA have enhanced opportu-
nities to build rapport and trust and to better tailor the
tone to the individual patient. Yet there is evidence that
HIV care providers may actually be less likely to recognize
current smoking in their patients [51,58]. This points to a
critical missed opportunity.
Notably, we found significantly higher motivational
readiness for cessation among individuals reporting smok-
ing status assessment by a physician, though not among
individuals reporting such assessment by a paramedic or
nurse. This implies that, in the context of this study set-
ting, the words of a physician may be imbued with greater
meaning or weight when it comes to issues of health beha-
viour change. Specifically, paramedics and nurses might be
perceived more as peers, as they are frequently available
for consultation in the NGO clinics. In contrast, interac-
tions with physicians typically occur in more formal
settings, where they may more likely be perceived as
expert service providers and their words afforded greater
value.
Drawing smokers’ attention to their smoking behaviour
is a form of feedback to the patient and might in itself be
sufficient to effect behaviour change when administered
by a trusted and valued health professional. While more
intensive, multifaceted counselling interventions may be
t h ei d e a l ,t h e ya r en o ta l w a y sf e a s i b l ei nb u s yp r i m a r y
care or clinical settings, particularly in low-resource
environments, where health care providers’ time is at a
premium. From a public health perspective, even given a
small effect size for facilitation of smoking cessation
through brief physician intervention, the net effect can
still be substantial, provided large numbers of physicians
follow such a practice systematically [59].
These results should be considered within the context of
several study limitations. First, although this study sur-
veyed a large group of participants from multiple NGO
outreach networks across the Kathmandu Valley, findings
are specifically representative of PLWHA falling within
the network of our partner NGOs. Importantly, our sam-
ple contained only two non-heterosexual participants,
though men who have sex with men represent an impor-
tant risk group in the HIV epidemic nationally. Second,
this study relies on self-report of all measures, leaving
room for several types of bias. Because information was
collected through face-to-face interviews, a social desir-
ability bias may have been introduced, though a confiden-
tial and sensitive method of survey administration was
designed to limit this tendency. Although we did not verify
smoking status biochemically for those who reported
being nonsmokers, there is empirical evidence that self-
report is a sufficient, reliable, and valid means to assess
smoking status [60].
Third, measurement of smoking status assessment
experiences in this study only covered the existence of
such an interaction and did not address potential varia-
bility in the specific content or quality of the discussions
on smoking taking place between patients and their phy-
sicians. Finally, though previous research has established
that stage of behaviour change effectively predicts both
smoking cessation attempts and actual cessation [29,30],
the tangible outcome variable of this study is readiness to
quit rather than eventual quitting success. Further
research will be needed to gain a better understanding of
the different nuances to effective delivery of smoking sta-
tus assessments in HIV care settings as well as the special
needs HIV-positive smokers may have in actually enact-
ing and maintaining smoking cessation.
Conclusions
Roughly one-third of HIV-positive smokers residing in
the Kathmandu Valley, Nepal, are at the contemplation
Amiya et al. BMC Public Health 2011, 11:677
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rates significantly higher among those whose physicians
have asked about their smoking status during any clini-
cal interaction over the past year. Although longitudinal
studies will be necessary to draw decisive conclusions,
our findings suggest an important role for physicians in
raising awareness and catalyzing change among their
currently smoking HIV-positive patients. Particularly in
an era of pervasive ART, the prevention of chronic,
tobacco-related disease represents an increasingly criti-
cal component of HIV medicine globally. Even through
the most minimal investment of time and resources,
HIV health care systems show promise as a gateway for
effective delivery of smoking cessation interventions to
the critical though neglected population of HIV-positive
smokers.
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